Komen Northeast Ohio Homepage

Letter from Sean Shacklett, Executive Director
The Northeast Ohio Affiliate responds to Peggy Orenstein's article, "The Problem with Pink" published in the New York Times Magazine..
More

Volunteer Training Opportunities
The Northeast Ohio Affiliate of Susan G. Komen is hosting 2 new training opportunities in May. If you are a current volunteer who is interested in receiving a refresher course, or if you are interested in becoming a volunteer, please join us May8th 1:00pm-4:00pm or May 11th 9:00am-12:00pm. .
More

KOMEN NORTHEAST OHIO TO PROVIDE OVER $900,000 IN LOCAL GRANTS
Most people recognize the Komen name from the Race for the Cure and other popular fundraising events. The bulk of the money raised supports worthy organizations and efforts to improve breast health and save lives across 22 Northeast Ohio counties. This year, the Northeast Ohio Affiliate of Susan G. Komen for the Cure® is contributing over $900,000 to 11 local organizations for projects supporting its promise to end breast cancer forever..
More

Volunteer For Komen NEO

Our volunteers come in all sizes, shapes and colors, but their hearts are pink and their caring has no limit. Are you a leader, a thinker or a doer? Use your talents in our promise to save lives and end breast cancer forever! We need you now more than ever.

Learn More

Shop Komen

Purchase with purpose to end breast cancer forever. Find everything you need to show your support for Komen.

Shop Now

Upcoming Events

Visit our event calendar for a full list of events in your area.

Is ductal carcinoma in situ (DCIS) breast cancer?
Ductal carcinoma in situ (DCIS) is breast cancer, but it is non-invasive. About 55,000 new cases of DCIS are expected to be diagnosed among women in the U.S. in 2013. Learn more now.

How Komen's research investment has changed the breast cancer landscape
As we've come to understand more about the biology of breast cancer, Komen's research agenda has changed tremendously over the past 10-15 years. Read more about Komen's research investment.